{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:56:55Z","timestamp":1793350615470,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Independent Innovation Research Fund of Huazhong University of Science and Technology","award":["2016YXMS109"],"award-info":[{"award-number":["2016YXMS109"]}],"id":[{"id":"https:\/\/ror.org\/00p991c53","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To report the main spectrum and new clinical and imaging characteristics of dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis, and to evaluate the effect of immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of nine patients with anti-DPPX encephalitis was performed, and all previously reported cases in the literature were reviewed. A cell-based indirect immunofluorescence assay using human embryonic kidney 293 cells transfected with DPPX was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine patients were identified (median age, 51\u2009years; range, 14\u201365\u2009years) with prodromal fever, diarrhea, or weight loss, followed by rapid progressive encephalopathy characterized by cognitive disorder. One patient who received methylprednisolone therapy and a trial of tacrolimus showed substantial improvement and had no relapse by the 6-month follow-up. Our comprehensive literature review demonstrated that 53 cases were reported, of which more than half had prodromal weight loss (52.8%) and gastrointestinal disorders (58.5%). Cognitive disorders (74.6%) and brainstem\/spinal cord disorders (75.5%) were the most common major symptoms. A greater proportion of Chinese patients than non-Chinese patients had abnormalities on brain magnetic resonance imaging specific for encephalitis (70.0% vs. 23.3%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Our study is the first to report three patients with anti-DPPX encephalitis who had sleep disorders with rapid eye movement sleep behavior disorder, limb paralysis (two), severe pleocytosis, elevated protein levels (two) in the cerebrospinal fluid, and increased T2\/FLAIR signal abnormalities in the bilateral hippocampus, temporal lobe, amygdala, basal ganglia, thalamus, centrum semiovale, and frontal and parietal lobes in seven patients (77.8%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study expands the clinical and imaging phenotypes of anti-DPPX encephalitis. Further studies elucidating the entire clinical spectrum of anti-DPPX encephalitis, its pathogenic mechanisms, and prognosis under long-term immunosuppressive therapy are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-022-02649-7","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:02:28Z","timestamp":1649120548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical and imaging analysis to evaluate the response of patients with anti-DPPX encephalitis to immunotherapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Jun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-cai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-8632","authenticated-orcid":false,"given":"Zhi-jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"issue":"1","key":"2649_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12883-017-0915-1","volume":"17","author":"H Posova","year":"2017","unstructured":"Posova H, Horakova D, Capek V, Uher T, Hruskova Z, Havrdova E. Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients. BMC Neurol. 2017;17(1):145.","journal-title":"BMC Neurol"},{"issue":"3","key":"2649_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276\u201386.","journal-title":"Lancet Neurol"},{"issue":"18","key":"2649_CR3","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ, Boulos M, Weaver S, Antoine JC, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77(18):1698\u2013701.","journal-title":"Neurology"},{"issue":"1","key":"2649_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013;73(1):120\u20138.","journal-title":"Ann Neurol"},{"issue":"1","key":"2649_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1073\/pnas.89.1.197","volume":"89","author":"K Wada","year":"1992","unstructured":"Wada K, Yokotani N, Hunter C, Doi K, Wenthold RJ, Shimasaki S. Differential expression of two distinct forms of mRNA encoding members of a dipeptidyl aminopeptidase family. Proc Natl Acad Sci U S A. 1992;89(1):197\u2013201.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2649_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0896-6273(02)01185-6","volume":"37","author":"MS Nadal","year":"2003","unstructured":"Nadal MS, Ozaita A, Amarillo Y, Vega-Saenz de Miera E, Ma Y, Mo W, et al. The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels. Neuron. 2003;37(3):449\u201361.","journal-title":"Neuron"},{"issue":"14","key":"2649_CR7","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","volume":"88","author":"M Hara","year":"2017","unstructured":"Hara M, Ari\u00f1o H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, et al. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology. 2017;88(14):1340\u20138.","journal-title":"Neurology"},{"issue":"20","key":"2649_CR8","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014;83(20):1797\u2013803.","journal-title":"Neurology"},{"issue":"3","key":"2649_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000086","volume":"2","author":"K Stoeck","year":"2015","unstructured":"Stoeck K, Carstens PO, Jarius S, Raddatz D, St\u00f6cker W, Wildemann B, et al. Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e86.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"2649_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000361","volume":"4","author":"L Doherty","year":"2017","unstructured":"Doherty L, Gold D, Solnes L, Probasco J, Venkatesan A. Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e361.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"2649_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000455","volume":"5","author":"J Wijntjes","year":"2018","unstructured":"Wijntjes J, Bechakra M, Schreurs MWJ, Jongen JLM, Koppenaal A, Titulaer MJ. Pruritus in anti-DPPX encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):e455.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"2649_CR12","first-page":"525","volume":"65","author":"G Valero-Lopez","year":"2017","unstructured":"Valero-Lopez G, Martin-Fernandez JJ, Hernandez-Clares R, Baidez-Guerrero AE, Martinez-Hernandez E. Progressive encephalitis due to anti-DPPX antibodies: a case with good response to treatment with rituximab. Rev Neurol. 2017;65(11):525\u20136.","journal-title":"Rev Neurol"},{"key":"2649_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577114","volume":"339","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Zhu X, Meng H, Zhang M, Chen S. Anti-dipeptidyl-peptidase-like protein 6 encephalitis, a rare cause of reversible rapid progressive dementia and insomnia. J Neuroimmunol. 2020;339:577114.","journal-title":"J Neuroimmunol"},{"key":"2649_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106093","volume":"197","author":"CG Bien","year":"2020","unstructured":"Bien CG, Schanzer A, Dargvainiene J, Dogan-Onugoren M, Woermann F, Strickler A. Co-occurrence of antibodies against dipeptidyl-peptidase-like protein-6 and aquaporin-4 during a case of paraneoplastic encephalitis. Clin Neurol Neurosurg. 2020;197:106093.","journal-title":"Clin Neurol Neurosurg"},{"issue":"17","key":"2649_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","volume":"82","author":"B Balint","year":"2014","unstructured":"Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Bl\u00f6cker IM, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology. 2014;82(17):1521\u20138.","journal-title":"Neurology"},{"issue":"10","key":"2649_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","volume":"85","author":"J Piepgras","year":"2015","unstructured":"Piepgras J, H\u00f6ltje M, Michel K, Li Q, Otto C, Drenckhahn C, et al. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology. 2015;85(10):890\u20137.","journal-title":"Neurology"},{"key":"2649_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/neuro.02.008.2008","volume":"1","author":"BD Clark","year":"2008","unstructured":"Clark BD, Kwon E, Maffie J, Jeong HY, Nadal M, Strop P, et al. DPP6 localization in brain supports function as a Kv4 channel associated protein. Front Mol Neurosci. 2008;1:8.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"2649_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1152\/physrev.00039.2003","volume":"84","author":"SG Birnbaum","year":"2004","unstructured":"Birnbaum SG, Varga AW, Yuan LL, Anderson AE, Sweatt JD, Schrader LA. Structure and function of Kv4-family transient potassium channels. Physiol Rev. 2004;84(3):803\u201333.","journal-title":"Physiol Rev"},{"issue":"1","key":"2649_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.20693","volume":"59","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59(1):178\u201381.","journal-title":"Ann Neurol"},{"key":"2649_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/B978-0-444-63432-0.00018-9","volume":"133","author":"MH Silber","year":"2016","unstructured":"Silber MH. Autoimmune sleep disorders. Handb Clin Neurol. 2016;133:317\u201326.","journal-title":"Handb Clin Neurol"},{"key":"2649_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/935379","volume":"2014","author":"A \u00c7oban","year":"2014","unstructured":"\u00c7oban A, Ismail K\u00fc\u00e7\u00fckali C, Bilgi\u00e7 B, Yal\u00e7\u0131nkaya N, Haytural H, Ulusoy C, et al. Evaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia. Behav Neurol. 2014;2014:935379.","journal-title":"Behav Neurol"},{"key":"2649_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.sleep.2018.01.006","volume":"44","author":"YQ Lin","year":"2018","unstructured":"Lin YQ, Chen SD. RBD: a red flag for cognitive impairment in Parkinson's disease? Sleep Med. 2018;44:38\u201344.","journal-title":"Sleep Med"},{"key":"2649_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"Heine J, Pr\u00fcss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis--Relevance for clinical practice and hippocampal function. Neuroscience. 2015;309:68\u201383.","journal-title":"Neuroscience"},{"issue":"1","key":"2649_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004563217724818","volume":"55","author":"AR Karim","year":"2018","unstructured":"Karim AR, Jacob S. Experience with newer central nervous system autoantibodies. Ann Clin Biochem. 2018;55(1):7\u201317.","journal-title":"Ann Clin Biochem"},{"key":"2649_CR25","doi-asserted-by":"crossref","unstructured":"Shan F, Long Y, Qiu W. Autoimmune glial Fibrillary acidic protein Astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.","DOI":"10.3389\/fimmu.2018.02802"},{"key":"2649_CR26","doi-asserted-by":"crossref","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial Fibrillary acidic protein Astrocytopathy. JAMA. Neurology. 2016;73(11):1297\u2013307.","DOI":"10.1001\/jamaneurol.2016.2549"},{"key":"2649_CR27","doi-asserted-by":"crossref","unstructured":"Kimura A, Takemura M, Yamamoto Y, Hayashi Y, Saito K, Shimohata T. Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications. J Neuroimmunol. 2019;334:576999.","DOI":"10.1016\/j.jneuroim.2019.576999"},{"issue":"2","key":"2649_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81(2):298\u2013309.","journal-title":"Ann Neurol"},{"issue":"8","key":"2649_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","volume":"22","author":"MG Huijbers","year":"2015","unstructured":"Huijbers MG, Querol LA, Niks EH, Plomp JJ, van der Maarel SM, Graus F, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol. 2015;22(8):1151\u201361.","journal-title":"Eur J Neurol"},{"key":"2649_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","volume":"9","author":"VS Mahajan","year":"2014","unstructured":"Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol. 2014;9:315\u201347.","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"2649_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Ari\u00f1o","year":"2016","unstructured":"Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, et al. Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology. 2016;87(8):759\u201365.","journal-title":"Neurology"},{"issue":"4","key":"2649_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14740338.2019.1599858","volume":"18","author":"T Jouve","year":"2019","unstructured":"Jouve T, Noble J, Rostaing L, Malvezzi P. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization. Expert Opin Drug Saf. 2019;18(4):285\u201394.","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"2649_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1389200219666180129151948","volume":"19","author":"M Yu","year":"2018","unstructured":"Yu M, Liu M, Zhang W, Ming Y. Pharmacokinetics, pharmacodynamics and Pharmacogenetics of Tacrolimus in kidney transplantation. Curr Drug Metab. 2018;19(6):513\u201322.","journal-title":"Curr Drug Metab"},{"issue":"4","key":"2649_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2174\/1389200219666180101104159","volume":"19","author":"K Schutte-Nutgen","year":"2018","unstructured":"Schutte-Nutgen K, Tholking G, Suwelack B, Reuter S. Tacrolimus - pharmacokinetic considerations for clinicians. Curr Drug Metab. 2018;19(4):342\u201350.","journal-title":"Curr Drug Metab"},{"issue":"7","key":"2649_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3349\/ymj.2019.60.7.633","volume":"60","author":"YH Kim","year":"2019","unstructured":"Kim YH, Shin HY, Kim SM. Long-term safety and efficacy of Tacrolimus in myasthenia gravis. Yonsei Med J. 2019;60(7):633\u20139.","journal-title":"Yonsei Med J"},{"issue":"1","key":"2649_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41598-017-00860-y","volume":"7","author":"B Chen","year":"2017","unstructured":"Chen B, Wu Q, Ke G, Bu B. Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder. Sci Rep. 2017;7(1):831.","journal-title":"Sci Rep"},{"key":"2649_CR37","doi-asserted-by":"crossref","unstructured":"Spindel J, Heckroth M, Marsano L. Antibody-negative autoimmune encephalitis as a complication of long-term immune-suppression for liver transplantation. BMJ Case Rep. 2020;13(9):e235777.","DOI":"10.1136\/bcr-2020-235777"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:07:25Z","timestamp":1649120845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02649-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-104470\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-104470\/v2","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tongji Hospital, and written informed consent was obtained from all patients or their surrogates before enrollment, for the use of serum, CSF, and clinical information for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}